Literature DB >> 16419113

Significance of hepatitis B virus genotypes A to E in a cohort of patients with chronic hepatitis B in the Seine Saint Denis District of Paris (France).

Nathalie Ganne-Carrié1, Virginie Williams, Halima Kaddouri, Jean-Claude Trinchet, Samira Dziri-Mendil, Chakib Alloui, Nasser Al Hawajri, Paul Dény, Michel Beaugrand, Emmanuel Gordien.   

Abstract

The aim of this study was to examine the genetic variability of the hepatitis B virus (HBV) and its significance. HBV genotypes, core promoter and precore mutants were characterized in 109 consecutive patients with biopsy-proven HBV chronic hepatitis. Genotypes A (26.6%), B (12.8%), C (18.3%), D (18.3%), and E (14.7%) indicate a wide genotypic distribution. Patients were from Asia (30.3%), Europe (28.4%), Sub Saharan Africa (23.9%), the Caribbean (10.1%), North Africa (5.5%), and Madagascar (1.8%). HBV genotypes A and D (HBV/A and /D) infected all subgroups except Asian patients. HBV/B or /C were found in 97% of Asian patients, whereas HBV/E only infected sub-Saharan African and Caribbean patients. Differences according to genotypes were: an increased prevalence of anti-HBe antibodies in patients infected with HBV/D (P = 0.003), higher serum transaminases in patients infected with HBV/A and/D (P = 0.043), more severe liver fibrosis in patients infected with HBV/A, /C and/D (P = 0.02). Precore and core promoter mutants were found in 87% of anti-HBe positive patients, and were associated with HBV/D (P = 0.04) and severe liver fibrosis (P = 0.002). It is concluded that HBV genotypes A, B, C, D, and E circulate in the Seine Saint Denis District, reflecting the geographical origin of patients. HBV/A, /C and/D seem to be associated with more severe hepatic disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16419113     DOI: 10.1002/jmv.20545

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  5 in total

1.  Hepatitis B virus sequencing and liver fibrosis evaluation in HIV/HBV co-infected Nigerians.

Authors:  Jennifer Grant; Oche Agbaji; Anna Kramvis; Mukhlid Yousif; Mu'azu Auwal; Sudhir Penugonda; Placid Ugoagwu; Robert Murphy; Claudia Hawkins
Journal:  Trop Med Int Health       Date:  2017-05-22       Impact factor: 2.622

2.  Liver stiffness measurement and biochemical markers in Senegalese chronic hepatitis B patients with normal ALT and high viral load.

Authors:  Papa Saliou Mbaye; Anna Sarr; Jean-Marie Sire; Marie-Louise Evra; Adama Ba; Jean Daveiga; Aboubakry Diallo; Fatou Fall; Loic Chartier; François Simon; Muriel Vray
Journal:  PLoS One       Date:  2011-07-25       Impact factor: 3.240

3.  Analysis of complete nucleotide sequences of Angolan hepatitis B virus isolates reveals the existence of a separate lineage within genotype E.

Authors:  Barbara V Lago; Francisco C Mello; Flavia S Ribas; Fatima Valente; Caroline C Soares; Christian Niel; Selma A Gomes
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

4.  High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance.

Authors:  Vincenzo Malagnino; Romina Salpini; Gaetano Maffongelli; Arianna Battisti; Lavinia Fabeni; Lorenzo Piermatteo; Luna Colagrossi; Vanessa Fini; Alessandra Ricciardi; Cesare Sarrecchia; Carlo Federico Perno; Massimo Andreoni; Valentina Svicher; Loredana Sarmati
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

5.  Molecular epidemiology and clinical characteristics of hepatitis B identified through the French mandatory notification system.

Authors:  Vincent Thibault; Syria Laperche; Valérie Thiers; Sophie Sayon; Marie-José Letort; Elisabeth Delarocque-Astagneau; Denise Antona
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.